Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
Article
Nature Medicine 12, 809 - 816 (2006)
Published online: 2 July 2006; | doi:10.1038/nm1440

E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis

Cho-Rok Jung, Kyung-Sun Hwang, Jinsang Yoo, Won-Kyung Cho, Jin-Man Kim, Woo Ho Kim & Dong-Soo Im

Supplementary Fig. 1 (pdf 100K)
F-UCP expressed in UCP-negative cells co-sediments with pVHL.

Supplementary Fig. 2 (pdf 92K)
UCP targets pVHL in cells under hypoxic conditions, thereby accumulating active HIF-1alpha.

Supplementary Fig. 3 (pdf 92K)
Recombinant GST-UCP, but not GST-UCPm is catalytically active.

Supplementary Fig. 4 (pdf 120K)
UCP ubiquitinates pVHL in vitro

Supplementary Fig. 5 (pdf 128K)
UCP specifically targets pVHL for degradation.

Supplementary Fig. 6 (pdf 88K)
UCP targets pVHL for degradation in Ck-K1 cells, thereby stabilizing HIF-1alpha.

Supplementary Fig. 7 (pdf 116K)
The specificity for UCP-siRNA.

Supplementary Fig. 8 (pdf 112K)
Detection of Ad.F-UCP genome and F-UCP transcript in tumors excised from mice.


 Top
SUPPLEMENTARY INFO
Back to article
Table of contents
Download plugins

Open Innovation Challenges

naturejobs

natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2006 Nature Publishing Group | Privacy policy